Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspecs Group Regulatory News (SPEC)

Share Price Information for Inspecs Group (SPEC)

Share Price is delayed by 15 minutes
Get Live Data
84.50    0.00 (0.00%)
Bid:
82.00
Ask:
87.00
Spread: 5.00 (6.098%)
Market Cap: £85.91m
SPEC Live PriceLast checked at - London Stock Exchange

Intraday Inspecs Group Share Chart

Form 8 (Opening Position Disclosure)

4 Dec 2025 07:00

RNS Number : 1739K
Inspecs Group PLC
04 December 2025
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

Amendment - this form replaces RNS number 1959G published at 07:00:09 on 5 November 2025, changes made to section 3a.

 

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Inspecs Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Inspecs Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

3 November 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of 1 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

Nil

Nil

Nil

Nil

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) Interests held by the directors of Inspecs Group plc, including their close relatives and related trusts:

 

Name

No. of ordinary shares of 1 pence each

% of interest held

Directors

Robin Totterman

19,024,262

18.71

Richard Peck

9,523

0.00

Christopher Hancock

23,448

0.00

Angela Farrugia

31,904

0.00

 

(b) Interests held as options or awards under the share plans of Inspecs Group plc by the directors of Inspecs Group plc and their close relatives and related trusts

 

Share scheme

Date of grant

Vesting date(s)

Expiration date

Exercise price per share (£)

No. of ordinary shares subject to award

Robin Totterman

LTIP

22/12/2020

22/12/2023

22/12/2030

2.10

150,000

Richard Peck

LTIP

22/12/2020

22/12/2023

22/12/2030

2.10

50,000

Robin Totterman

LTIP

23/12/2021

23/12/2024

23/12/2031

3.70

50,000

Richard Peck

LTIP

04/06/2025

01/05/2026

01/05/2031

0.01

250,000

Richard Peck

LTIP

04/06/2025

01/05/2027

01/05/2032

0.01

150,000

Total:

650,000

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

3 December 2025

Contact name:

Elliott Smith, Company Secretary

Telephone number:

+44 (0)1225 717000

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEFFFLFFDLVIIE
Date   Source Headline
15th Sep 20225:44 pmRNSHolding(s) in Company
7th Sep 20227:00 amRNSDirector/PDMR Share Dealing
30th Aug 20224:52 pmRNSHolding(s) in Company
23rd Aug 20225:02 pmRNSHolding(s) in Company
18th Aug 20227:00 amRNSInterim Results
11th Aug 20223:31 pmRNSResult of AGM
11th Jul 20221:19 pmRNSDirector/PDMR Shareholding
4th Jul 20227:00 amRNSDirector/PDMR Shareholding
1st Jul 20222:26 pmRNSDirector/PDMR Dealing
29th Jun 202212:37 pmRNSDirector/PDMR Shareholding
29th Jun 20227:00 amRNSFinal Results
24th Jun 20227:00 amRNSNotice of Final Results
7th Jun 20224:38 pmRNSHolding(s) in Company
31st May 202211:14 amRNSHolding(s) in Company
17th May 20225:41 pmRNSChange to Publication Date of Results
27th Apr 20227:00 amRNSQ1 Trading Update and Notice of Results
31st Mar 20224:17 pmRNSDirector/PDMR Share Dealing
18th Mar 202210:09 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSDirector/PDMR Share Dealing
1st Feb 20227:00 amRNSFull Year Trading Update
24th Jan 20227:00 amRNSHolding(s) in Company
11th Jan 20227:00 amRNSHolding(s) in Company
6th Jan 20227:00 amRNSAllotment of shares
24th Dec 20218:14 amRNSDirector/PDMR Share Dealing
23rd Dec 20217:00 amRNSAcquisition of Ego Eyewear
8th Dec 20217:00 amRNSAcquisition of BoDe
28th Oct 20217:00 amRNSQ3 Trading Update
20th Oct 20215:13 pmRNSHolding(s) in Company
8th Sep 20217:00 amRNSInterim Results
13th Aug 20217:00 amRNSNotice of Results
19th Jul 202111:42 amRNSResult of AGM
25th Jun 20217:00 amRNSAnnual Report and Notice of Annual General Meeting
21st Jun 20217:00 amRNSDirector/PDMR Dealing
18th Jun 20217:00 amRNSFinal Results
29th Apr 20217:00 amRNSQ1 Trading Update & Notice of Results
26th Feb 20217:00 amRNSDirector/PDMR LTIP Awards
8th Feb 20215:57 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSFull Year Trading Update
13th Jan 20218:25 amRNSHolding(s) in Company
23rd Dec 20204:21 pmRNSDirector/PDMR LTIP Awards
11th Dec 20201:05 pmRNSHolding(s) in Company
11th Dec 202012:00 pmRNSHolding(s) in Company
11th Dec 202011:58 amRNSDirector/PDMR Share Dealings
10th Dec 20203:11 pmRNSEschenbach Acquisition satisfaction of condition
7th Dec 20201:01 pmRNSResult of General Meeting
20th Nov 20207:00 amRNSPublication of Circular and Notice of GM
19th Nov 20202:05 pmRNSResult of Placing and Total Voting Rights
19th Nov 20207:00 amRNSProposed Placing
19th Nov 20207:00 amRNSProposed Acquisition of Eschenbach Holding GmbH
14th Oct 20201:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.